Black Creek Investment Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
HM
Black Creek Investment Management's HAE Position: Q4 2017 in Review
Black Creek Investment Management sold out of Haemonetics (HAE) in Q4 2017, closing a stake of 649,748 shares — an estimated $29.2M sold.
Black Creek Investment Management first reported a position in HAE in Q3 2013 and held it in 17 quarters. The position peaked at $87.3M in Q1 2016. 246 funds tracked by Wall St. Rank hold HAE as of Q4 2017.
- Black Creek Investment Management reported no remaining Haemonetics position as of Q4 2017 after selling out during the quarter.
- Black Creek Investment Management sold 649,748 Haemonetics shares in Q4 2017, an estimated $29.2M.
- Black Creek Investment Management first reported a position in Haemonetics in Q3 2013 and held it in 17 quarters.
- Black Creek Investment Management's Haemonetics position peaked at $87.3M in Q1 2016.
- 246 funds tracked by Wall St. Rank held Haemonetics as of Q4 2017.
Based on Black Creek Investment Management's 13F filing for Q4 2017, filed 9 Feb 2018.